Source:http://linkedlifedata.com/resource/pubmed/id/18819819
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2008-11-17
|
pubmed:abstractText |
Children with steroid sensitive nephrotic syndrome (SSNS) is thought to have dysregulated type-1/type-2 cytokine network. Interleukin (IL)-18 is a cytokine, which may enhance both type-1 and type-2 responses, depending on the cytokines milieu. This prospective study aimed to assess type-1/type-2 cytokine synthesis and production profile in different stages of SSNS and define the potent involvement of IL-18. Twenty-three children with SSNS, aged 2.5-14 years, were studied; 23/23 both in active stage before treatment initiation and in remission still on steroids; 15/23 in remission off steroids as well. Data were compared with those obtained from 25 age-matched controls. The following parameters were assessed: Basic T cell populations, percentages of CD3+/CD69+/IFN-gamma+ and CD3+/CD69+/IL-4+ T cells as well as serum levels of IFN-gamma, IL-2, IL-4, IL-13 and IL-18. No difference in IL-2 levels was found between nephrotic children of all disease stages and controls (p>0.05). Percentage of CD3+/CD69+/IL-4+ T cells and serum levels of IL-4, IL-13 and IL-18 were significantly higher in the active stage of SSNS compared with the remission stages and controls (p<0.05). On the contrary, percentage of CD3+/CD69+/IFN-gamma+ T cells as well as serum IFN-gamma were significantly lower during active disease stage compared with remission stages and controls (p<0.05). In children with SSNS, of all disease stages, serum levels of IL-18 were significantly correlated with both IL-4 and IL-13 (r=0.628 and p<0.0001, r=0.71 and p<0.0001, respectively). It seems that a type-2 cytokine synthesis and production pattern prevails in children with active SSNS and IL-18 expression is significantly correlated with this type-2 immune response.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-13,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-18,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-2,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-4,
http://linkedlifedata.com/resource/pubmed/chemical/Steroids
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1096-0023
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
44
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
262-8
|
pubmed:meshHeading |
pubmed-meshheading:18819819-Child,
pubmed-meshheading:18819819-Humans,
pubmed-meshheading:18819819-Immunophenotyping,
pubmed-meshheading:18819819-Interferon-gamma,
pubmed-meshheading:18819819-Interleukin-13,
pubmed-meshheading:18819819-Interleukin-18,
pubmed-meshheading:18819819-Interleukin-2,
pubmed-meshheading:18819819-Interleukin-4,
pubmed-meshheading:18819819-Nephrotic Syndrome,
pubmed-meshheading:18819819-Regression Analysis,
pubmed-meshheading:18819819-Remission Induction,
pubmed-meshheading:18819819-Steroids
|
pubmed:year |
2008
|
pubmed:articleTitle |
IL-18 is correlated with type-2 immune response in children with steroid sensitive nephrotic syndrome.
|
pubmed:affiliation |
First Department of Pediatrics, Aristotle University of Thessaloniki, Hippokration General Hospital, Konstantinoupoleos 49, 54642, Thessaloniki, Greece. nprintza@in.gr
|
pubmed:publicationType |
Journal Article
|